Tricuspid atresia epidemiology and demographics

Tricuspid atresia Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Tricuspid Atresia from other Disorders
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Cardiac Catheterization
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Special Scenarios
Pregnancy
Case Studies
Case #1
Tricuspid atresia epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tricuspid atresia epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tricuspid atresia epidemiology and demographics
CDC on Tricuspid atresia epidemiology and demographics
Tricuspid atresia epidemiology and demographics in the news
Blogs on Tricuspid atresia epidemiology and demographics
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Tricuspid atresia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor-In-Chief:; Sara Zand, M.D.[2] Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [4]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [5]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Prevalence

• Worldwide, the prevalence of tricuspid atresia is 7.8 per 100,000 persons.

Age

• Tricuspid atresia is a congenital heart disease observed among infants at the time of birth.

Gender

• Tricuspid atresia affects males and females equally.

Race

• There is no racial predilection for tricuspid atresia